HCG Q1 FY27 results: Revenue up 13%, EBITDA up 20%, PAT jumps 190% YoY

Profit growth above 25%EBITDA margin expansionExceptional itemResults View source PDF Explain this filing

HCG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.6%Reaction day

₹674.00

prior close

₹670.10

announcement price

After-mkt

timing

Nifty Microcap 250market+0.0%+0.6% vs market

Hospital peers, median of 26sector+0.2%+0.4% vs sector

On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 0.4 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

-1.0

15m

-1.5

30m

-1.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.6+0.0+0.6+0.2+0.4

Next day

+6.2-0.0+6.2-0.1+6.3

+8.1-0.2+8.3-0.4+8.6

+9.3+0.2+9.2-2.1+11.5

+7.1+0.3+6.8-3.0+10.1

+6.0+0.4+5.6-1.7+7.7

+5.8+0.9+4.9-1.6+7.3

15d

+3.1+1.6+1.5-3.1+6.1

+2.3+2.0+0.3-2.5+4.8

-2.4+0.6-2.9-10.4+8.1

—————

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

HCG reported Q1 FY27 consolidated revenue of Rs 6,951 Mn, up 13% YoY from Rs 6,132 Mn. Adjusted EBITDA rose 20% YoY to Rs 1,339 Mn with margins expanding 121 bps to 19.4%. Adjusted PAT surged 190% to Rs 138 Mn. Volume grew 11%, ARPP up 2%. New North Bangalore hospital contributed Rs 67 Mn. Fertility business divested in June 2026. Added 121 beds across network.

Likely market impact

Strong start to FY27 with revenue and EBITDA both growing double-digit. Margin expansion and PAT surge signal improving profitability.